KR100785375B1 - Feed for prevention of heavy metal poisoning - Google Patents

Feed for prevention of heavy metal poisoning Download PDF

Info

Publication number
KR100785375B1
KR100785375B1 KR1020060137417A KR20060137417A KR100785375B1 KR 100785375 B1 KR100785375 B1 KR 100785375B1 KR 1020060137417 A KR1020060137417 A KR 1020060137417A KR 20060137417 A KR20060137417 A KR 20060137417A KR 100785375 B1 KR100785375 B1 KR 100785375B1
Authority
KR
South Korea
Prior art keywords
feed
heavy metal
test
herbal medicine
organic selenium
Prior art date
Application number
KR1020060137417A
Other languages
Korean (ko)
Inventor
손영희
이익재
Original Assignee
주식회사 과학기술분석센타
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 과학기술분석센타 filed Critical 주식회사 과학기술분석센타
Priority to KR1020060137417A priority Critical patent/KR100785375B1/en
Application granted granted Critical
Publication of KR100785375B1 publication Critical patent/KR100785375B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/37Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals

Abstract

Feed for the prevention of heavy metal poisoning is provided to prevent a disease-causing factor of livestock or a pet and supply higher value-added functional feed. Feed for the prevention of heavy metal poisoning comprises 2ppm of organic selenium and 2~4ppm of the powder of dregs obtained from the distillation of medicinal herbs. The powder of dregs obtained from the distillation of medicinal herbs includes licorice and polyphenol. The licorice contains liquiritigenin capable of preventing cells from being damaged by heavy metals, and most of the liquiritigenin is included in the powder of dregs obtained from the distillation of medicinal herbs. In addition, polyphenol has an antioxidant effect and so promote the health of animals. The organic selenium such as selenomethionine, selenocysteine, or methylselenocysteine has anti-oxidant, anti-cancer, and anti-inflammatory effects.

Description

중금속중독 예방을 위한 사료. {Feed for prevention of heavy metal poisoning}Feed for the prevention of heavy metal poisoning. {Feed for prevention of heavy metal poisoning}

도 1은 Liposome의 모식도이고,1 is a schematic diagram of Liposome,

도 2는 시험기간 중 SD의 체중변화를 나타낸 그래프이며,2 is a graph showing the weight change of the SD during the test period,

도 3은 시험기간 중 간의 산화지수를 나타낸 그래프이고,3 is a graph showing the oxidation index during the test period,

도 4는 시험기간 중 혈청의 산화지수를 나타낸 그래프이며,4 is a graph showing the oxidation index of serum during the test period,

도 5는 혈중 sGOT, sGPT의 수치를 나타낸 그래프이다.5 is a graph showing the levels of sGOT and sGPT in blood.

생물학적 시료에서의 중금속의 침착 정도에 대한 평가는 식품과 사료를 기점으로 한 안정성 평가에서부터 시작하여 진단 및 처방을 위한 임상시험에 이르기까지 다양한 시도가 이루어지고 있으며, 원인을 찾기 위한 기초 연구부터 진단 및 처방을 위한 최신 연구에 이르기까지 지속적인 연구 대상이 되어 왔다. 일반적으로 중금속의 침착 정도를 시험하기 위한 기법을 통해 생체의 건강상태 및 특정 환경에 서의 영향을 파악하기 위하여 혈액, 소변, 머리카락 등 신체의 일부를 취하여 시험 및 검사하는 방법이 통용되고 있으나, 혈액과 소변을 검체로 하기에는 채취 과정의 번거로움과 생육 환경의 다양성에 대한 변이성이 존재하는 단점 및 대상 개체가 갖는 다양한 형태의 병력에 대한 추적 등에 대한 시간적 공간적 제한요소들이 산재해 발병초기부터 중독증상의 정도를 추적하기에 역부족이다. 반면 모발의 경우에는 시료의 채취도 용이하고 지난 3~4개월 동안의 생육 환경에 대한 외인적, 내인적 영향까지 파악할 수 있는 장점이 있으므로, 모발을 이용하여 중금속 노출 및 필수 극미량 원소의 상태 등을 조사하는 방법은 매우 유용한 진단법으로 기대된다.The assessment of the degree of deposition of heavy metals in biological samples ranges from food and feed stability assessments to clinical trials for diagnosis and prescription. It has been the subject of continuous research up to the latest research for prescriptions. In general, a technique for testing the degree of deposition of heavy metals to take a part of the body, such as blood, urine, hair, etc. in order to determine the health of the living body and its impact on a specific environment, but the blood is commonly used In the case of the urine and urine specimens, there is a problem of the cumbersome sampling process and the variation of the diversity of the growing environment, and the temporal and spatial limitations on the tracking of various types of medical history of the subject, and the degree of symptoms of intoxication from the beginning of the onset. Not enough to track it. On the other hand, hair is easy to collect samples and has the advantage of being able to grasp the external and internal influences on the growth environment for the last 3-4 months. The method of investigation is expected to be a very useful diagnostic.

진단을 통해 확인한 중금속의 중독증상을 치유하고자 하는 시도 또한 서양의학과 동양의학을 막론하고 주요 관심사로 다뤄졌으며, 지금까지의 연구 결과 식물체에 함유된 다양한 Polyphenol이 중금속의 중독증상을 억제하는 것으로 밝혀졌다. 현재까지 알려진 중금속 해독방법으로는 셀룰로오스, 펙틴, 키토산, 알긴산, 리그닌 등의 난소화 점착성 고분자 당이 갖는 수착능력을 활용한 방법과, 맥주, 효모, 미생물 대사물질, 유사호르몬 등의 이뇨촉진제를 사용한 배출방법, 비타민, 항산화제 등을 이용한 세포면역능력 증가 등의 방법이 알려져 있고, 그 외 직접적인 해독능력을 갖는 물질로서 리퀴리티게닌에 대한 연구도 진행되고 있다.Attempts to cure heavy metal poisoning symptoms identified through diagnosis have been addressed as a major concern regardless of western medicine and oriental medicine. To date, studies have shown that various polyphenols contained in plants suppress heavy metal poisoning symptoms. Heavy metal detoxification methods known to date include methods using the sorption capacity of indigestible adhesive polymer sugars such as cellulose, pectin, chitosan, alginic acid, and lignin, and diuretic accelerators such as beer, yeast, microbial metabolites, and similar hormones. Methods for increasing cellular immunity using a release method, vitamins, antioxidants, and the like are known, and research on liquirigenin as a substance having direct detoxification ability is also underway.

한편, 기능성 사료의 개발도 꾸준히 진행되어 대한민국 등록특허공보 특 제0181679호 셀레늄함유 사료 조성물 및 이를 이용한 셀레늄함유 축산물의 생산방법에서는 셀레노메티오닌을 0.05-5ppm 함유하는 사료조성물을 급여하여 셀레늄이 고도로 축적된 축산물을 생산하는 방법을 제공하였으며, 대한민국 공개특허공보 제 10-2005-0068526호 셀레늄을 유효성분으로 함유하는 배합사료 및 이를 이용한 기능성 축산물과 과채류의 제조방법에서는 유기태 및 무기태 셀레늄을 0.1-2.0ppm 첨가한 배합사료를 가축에 급여함으로써 셀레늄을 다량 함유하는 축산물을 생산하는 방법을 제공한 바 있다. 그러나, 상기 방법들은 셀레늄을 함유하는 축산물을 생산하기 위한 것이므로 가축이나 애완동물의 중금속중독을 예방 및 치료하는 목적과는 거리가 멀다.On the other hand, the development of functional feed has also been steadily progressed, and in the Korean Patent Application Publication No. 0181679 Selenium-containing feed composition and the method of producing livestock products containing selenium, selenium is highly accumulated by feeding a feed composition containing 0.05-5 ppm of selenium methionine. The present invention provides a method for producing livestock products, and in the combination feed containing selenium as an active ingredient and a method for producing functional livestock and fruit vegetables using the same, 0.1-2.0 organic and inorganic selenium The company has provided a method for producing livestock products containing a large amount of selenium by feeding the compound feed with the addition of ppm. However, the above methods are intended to produce livestock products containing selenium, which is far from the purpose of preventing and treating heavy metal poisoning in livestock or pets.

또한, 대한민국 등록특허공보 제10-0463805호 애견사료 및 제조방법에서는 천궁 5.5%, 산조인 4.2%, 원지 4.2%, 복신 4.2%, 지황 5.5%, 반하 5.5%, 인삼 5.5%, 죽여 2.8%, 지실 2.8%, 황금 4.2%, 감초 2.7%, 작약 5.5%, 방충 4.2%, 창출 5.5%, 후박 4.2%, 진피 4.2%, 사인 4.2%, 현삼 2.8%, 향부자 5.5%, 곽향 2.8%, 대추 5.5%, 생강 2.7%, 강활 4.2%로 이루어진 애견사료를 제공하였고, 등록특허공보 제10-0495605호 육계용 한방사료첨가제와 그 제조방법에서는 황금 10중량%, 석창포 15중량%, 어성초 10중량%, 홍화 30중량%, 구기자 10중량%, 방기 10중량%, 포도당 15중량%를 함유하는 한방사료첨가제를 제공하였다. 상기 사료첨가제, 또는 사료들은 한약재의 성분을 함유하고 있지만 한약재 성분을 첨가하는 목적이 중금속 중독증상의 예방, 치료와는 관계가 없다.In addition, in the Republic of Korea Patent Publication No. 10-0463805, dog food and manufacturing method: 5.5% cheongung, 4.2% sanjoin, 4.2% raw paper, Fuxin 4.2%, 5.5% turmeric, 5.5% half ginseng, 5.5% ginseng, 2.8% killed 2.8%, Golden 4.2%, Licorice 2.7%, Peony 5.5%, Insect Repellent 4.2%, Creation 5.5%, Thick 4.2%, Dermis 4.2%, Cod 4.2%, Hyunsam 2.8%, Hyangbu 5.5%, Gwakyang 2.8%, Jujube 5.5% Provided dog feed consisting of, ginger 2.7%, vigor 4.2%, in Korean Patent Publication No. 10-0495605, the herbal feed additive for broiler chicken and its manufacturing method 10% by weight of gold, 15% by weight of Seokchangpo, 10% by weight of edible vinegar, safflower An herbal feed additive containing 30% by weight, wolfberry 10% by weight, airborne 10% by weight, and 15% by weight glucose was provided. The feed additives, or feeds contain the components of the herbal medicine, but the purpose of adding the herbal medicine components has nothing to do with the prevention and treatment of heavy metal poisoning symptoms.

본 발명은 중금속 중독증상을 예방 및 치료할 수 있는 사료를 제공하여, 가축과 애완동물의 질병 요인을 막고 건강을 유지하는 것을 목적으로 한다.An object of the present invention is to provide a feed for preventing and treating heavy metal poisoning symptoms, to prevent disease factors of livestock and pets and to maintain health.

본 발명의 중금속중독 예방을 위한 사료는 한약박과 유기셀레늄을 함유하고 있다.Feed for the prevention of heavy metal poisoning of the present invention contains herbal medicine and organic selenium.

한약박은 한약재를 증류하고 남은 찌꺼기로 다양한 약재의 성분을 함유하고 있는데, 그중에서도 감초는 여러 약재들을 조화시키는 역할을 하므로 대부분의 한약에 포함되는 기본 약재로 한약박에도 상당량이 포함되어 있다. 감초에는 리퀴리티게닌(liquiritigenin)이 함유되어 중금속으로 인한 세포손상을 방지해 주는 효과가 있으며, 리퀴리티게닌은 물에 용해되지 않으므로 한약 제조시에 추출되지 않고 대부분이 한약박에 포함되어 있다. 또한, 한약박에 포함되어 있는 폴리페놀 성분은 항산화효과를 나타내므로 동물의 건강증진에 도움을 주며, 고가의 한약재를 대신하여 한약박을 사용함으로써 비용을 크게 절감할 수 있다.Herbal medicine is the residue left after distilling the herbal medicine contains the ingredients of various herbs, among which licorice plays a role in harmonizing various herbs, so the main medicine included in most herbal medicine is included in the herbal medicine. Licorice contains liquiritigenin to prevent cell damage due to heavy metals.Liquirigenin is not soluble in water, so it is not extracted during the manufacture of Chinese medicine. . In addition, the polyphenol component contained in the herbal medicine has an antioxidant effect, which helps to improve the health of the animal, and can greatly reduce the cost by using the herbal medicine instead of expensive herbal medicine.

셀레늄은 항산화, 항암, 항염증 작용을 하며, 갑상선 기능 및 면역기능을 활성화하는 효과를 나타내는 물질이다. 무기셀레늄은 독성이 강하므로 섭취용으로는 주로 셀레노메티오닌, 셀레노시스테인, 메틸셀레노시스테인과 같은 유기셀레늄을 사용한다.Selenium is an antioxidant, anti-cancer, anti-inflammatory action, and is a substance that shows the effect of activating the thyroid function and immune function. Since inorganic selenium is highly toxic, organic selenium such as selenomethionine, selenocysteine, and methyl selenocysteine is mainly used for ingestion.

본 발명에서는 중금속 중독증상 예방 및 치료를 위한 물질인 감초 내 리퀴리티게닌의 급여원으로서 경제적 가치를 고려해 한약 증류 찌꺼기인 한약박을 (주)윤선기퍼맨트로부터 공급받아 건조, 분말화한 후 사용하였으며, 유기셀레늄은 (주)대 한뉴팜에서 공급받아 사용했다. 한약박과 유기셀레늄 원료의 능력 평가를 위하여, 상기 물질의 대표적 기능으로 알려진 항산화능력을 Liposome을 제조하여 시험하였다. 또한, ICP(Inductivity Coupled Plasma)-AES(Ultima-2C)를 통하여 애완견의 축종에 따라 모발을 분석한 결과, 염증과 관련된 병력이 있는 견종의 중금속 침착도가 높게 나타났으므로, 한약박과 유기 셀레늄을 이용한 항염증 시험도 실시하였다.In the present invention, it is used after drying, powdering and receiving the herbal medicine distillation residue of medicinal herb from Yoonsun Giper Co., Ltd. in consideration of economic value as a salary source of liquiriginine in licorice, which is a substance for preventing and treating heavy metal poisoning symptoms. Organic selenium was supplied from Hannew Farm Co., Ltd. and used. In order to evaluate the capability of the herbal medicine and the organic selenium raw material, the antioxidant capacity known as the representative function of the material was tested by preparing Liposome. In addition, as a result of analyzing the hair according to the breeding of the dog through ICP (Inductivity Coupled Plasma) -AES (Ultima-2C), the degree of heavy metal deposition of the dogs with the history of inflammation was high. The anti-inflammatory test was also conducted.

[실험예 1] Liposome을 기질로 한 항산화 및 항염증 능력 시험Experimental Example 1 Antioxidant and Anti-inflammatory Capacity Test Using Liposome as Substrate

Liposome은 인지질을 수용액에서 현탁시켜 제조하며, 내부가 액상으로 존재하는 지질 이중층(Lipid bilayer)의 closed vesicle로서 생체막과 가장 유사한 형태를 가져 다양한 방면의 연구에 활용된다. Liposome이 만들어지는 현상은 인지질 분자가 본래 가지고 있는 성질에서 유래한다. 즉, 분자내 극성기와 비극성기가 있는 양친매성 화합물이기 때문에 극성기는 수용액 측을 향하며, 비극성기는 소수성 상호작용에 의해 모이는 경향이 있다. 본 발명에서는 항산화 활성평가를 위한 생체막 모델로서 Liposome을 이용하였다.Liposomes are prepared by suspending phospholipids in aqueous solutions. Liposomes are closed vesicles of lipid bilayers, which are liquid phases, and have the most similar form to biofilms. The phenomenon of liposomes originates from the nature of phospholipid molecules. That is, since it is an amphiphilic compound having an intramolecular polar group and a nonpolar group, the polar group is directed toward the aqueous solution side, and the nonpolar group tends to be collected by hydrophobic interaction. In the present invention, Liposome was used as a biofilm model for antioxidant activity evaluation.

[실험예 1-1] Liposome 조제Experimental Example 1-1 Preparation of Liposome

EYPC(Egg yolk phosphatidylcholine) 50mg을 Test Tube에 넣고 유기용매를 Nitrogen gas로 제거하고, RP column(Lichroprep Lobar column, RP-8, 40~63mm, 240×10mm, Merck)을 이용하여 1ml 단위로 Fraction 한 후(CHCl3-MeOH-H2O (1:10:0.5, v/v), 1.8ml/min), HPTLC를 이용해 각 Fraction단위를 전개하여 용출분획을 확인하였다(약 35~55ml의 용출 범위, HPTLC plate(RP-8 F254s, Merck), CHCl3-MeOH-H2O (1:10:0.5, v/v), Iodine vapor(발색-인)). 상기 용출분획을 합쳐서 용매를 제거하고 CHCl3-MeOH (95:5, v/v)에 용해하여 5ml을 Test tube에 넣고 tube 외벽에 얇은 film이 되도록 도포하고 nitrogen gas로 용매를 제거하고 진공 데시케이터에서 30분간 더 건조시켜 용매를 완전 제거하였다. Tris-HCl buffer 0.7ml을 가하고 Vortex로 1분간 교반하여 Film층을 벗겨내고, Sonicator상에서 30초간 분산시켜 200~5,000nm로 만든 후, LipoFast(Avestin Co., Ottawa, Canada)에 polycarbonate membrane(Pore size 100nm)을 걸어 100nm크기의 LUV(Large unilamella vesicle)를 제조하였다.Put 50mg of EYPC (Egg yolk phosphatidylcholine) into the test tube, remove the organic solvent with Nitrogen gas, and fractionate in 1ml by using RP column (Lichroprep Lobar column, RP-8, 40 ~ 63mm, 240 × 10mm, Merck) After (CHCl 3 -MeOH-H 2 O (1: 10: 0.5, v / v), 1.8ml / min), each fraction unit was developed using HPTLC to confirm the elution fraction (elution range of about 35-55ml). , HPTLC plate (RP-8 F254s, Merck), CHCl 3 -MeOH-H 2 O (1: 10: 0.5, v / v), Iodine vapor (chromo-phosphorus)). The elution fractions were combined to remove the solvent, dissolved in CHCl 3 -MeOH (95: 5, v / v), 5ml was placed in a test tube, applied to form a thin film on the outer wall of the tube, the solvent was removed with nitrogen gas and vacuum desiccated. Drying in the furnace for 30 minutes further removed the solvent completely. 0.7 ml of Tris-HCl buffer was added and stirred for 1 minute with Vortex to peel off the film layer, dispersed for 30 seconds on a sonicator to make 200-5,000 nm, and then polycarbonate membrane (Pore size) in LipoFast (Avestin Co., Ottawa, Canada). 100 nm) was used to prepare a large unilamella vesicle (LUV) having a size of 100 nm.

[실험예 1-2] FOX Assay (Ferrous Oxidation in Xylenol orange assay)Experimental Example 1-2 FOX Assay (Ferrous Oxidation in Xylenol orange assay)

지질의 산화과정은 Hydroperoxide의 생성과 Malonaldehyde의 생성으로 설명할 수 있다. 즉, 항산화효과란 간단히 말해서 상기한 두 가지 물질의 생성을 억제하고 환원하는 기작을 말하는 것이다. Hydroperoxide는 지질의 산패과정 중 발생하는 과산화물이며 생체에 산화 스트레스를 유발하는 원인 물질이다. 따라서, 한약박과 유기셀레늄의 항산화효과는 상기 물질에 대한 억제효과로 확인할 수 있으며, 이를 위하여 FOX Assay를 실시하였다. 표 1에 기재된 바와 같이 산화유발제인 AAPH(2,2'-azobis-2-amidinopropane-dihydrochloride)를 Liposome에 60mg/kg의 농 도로 첨가하였으며, 측정대상 기능성물질은 표 2에 기재된 농도에 맞도록 각각 첨가하였다.The oxidation of lipids can be explained by the production of hydroperoxide and the production of malonaldehyde. In other words, the antioxidant effect simply refers to a mechanism for inhibiting and reducing the production of the two substances described above. Hydroperoxide is a peroxide that occurs during the rancidity of lipids and is a source of oxidative stress in the living body. Therefore, the antioxidant effect of the herbal medicine and organic selenium can be confirmed as an inhibitory effect on the substance, for which FOX assay was performed. As shown in Table 1, AAPH (2,2'-azobis-2-amidinopropane-dihydrochloride), which is an oxidizing agent, was added to Liposome at a concentration of 60 mg / kg, and the functional substances to be measured were adjusted to meet the concentrations shown in Table 2, respectively. Added.

[실험방법 1-2] FOX Assay[Experimental Method 1-2] FOX Assay

Xylenol orange 38mg, 440mg을 HPLC급 메탄올 450ml에 용해하고, Ammonium ferrous sulfate 49mg을 250mM sulfuric acid 50ml에 용해한 후 이를 위 용매에 가한다. 최종 용매의 조건은 Xylenol Orange 100μmol/l, 4mM BHT, 25mM sulfuric acid, Ammonium ferrous sulfate 250μmol/l를 90% 메탄올에 용해한 형태로 조제하고, 용매의 교정은 매회 560nm에서 일정 농도의 Hydrogen peroxide와의 반응을 측정하여 수치 변화를 체크한다(3.72×104/Mcm이상 유지). 상기 용액을 표준물질과의 검량선을 작성하며 반응시간 37℃, 10분간 암소에서 Liposome 300㎕와 반응시켜 측정한다.Xylenol orange 38mg, 440mg is dissolved in 450ml HPLC grade methanol, 49mg Ammonium ferrous sulfate is dissolved in 50ml 250mM sulfuric acid and added to the above solvent. Final solvent was prepared by dissolving Xylenol Orange 100μmol / l, 4mM BHT, 25mM sulfuric acid and Ammonium ferrous sulfate in 250% mol / l in 90% methanol. Measure and check the numerical change (keep 3.92 × 10 4 / Mcm or more). The solution is measured by preparing a calibration curve with a standard material and reacting with 300 μl of Liposome in the dark at a reaction time of 37 ° C. for 10 minutes.

[실험예 1-3] TBArs assay (Thiobarbituric acid reactive substance assay)Experimental Example 1-3 TBArs assay (Thiobarbituric acid reactive substance assay)

대표적인 항산화능력 평가항목으로서 지질 산화과정에 의해 계속적으로 증가하는 Malonaldehyde의 양을 TBArs assay를 통해 측정하였다. 산화유발제인 AAPH(2,2'-azobis-2-amidinopropane-dihydrochloride)를 Liposome에 60mg/kg의 농도로 첨가하였으며, 측정대상 기능성 물질은 표 3에 기재된 농도에 맞도록 각각 첨가하였다.As a representative measure of antioxidant capacity, the amount of Malonaldehyde continuously increased by lipid oxidation was measured by TBArs assay. Oxidation-inducing agent AAPH (2,2'-azobis-2-amidinopropane-dihydrochloride) was added to Liposome at a concentration of 60 mg / kg, and the functional material to be measured was added to meet the concentrations listed in Table 3.

[실험방법 1-3] TBArs assay[Test Method 1-3] TBArs assay

Liposome 300㎕와 측정대상 기능성 물질을 Test tube에 넣고, SDS(200㎕, 8.1% in water, v/v), acetic acid(1.5ml, 20%, w/v, 15% NaOH(w/v)로 pH4.0조절), 2-thiobarbituric acid(1.5ml, 0.8% in water, w/v), BHT(0.5ml, 0.08% in MeOH, w/v)를 가한다. 이를 수욕상에서 95℃에서 60분간 반응시키고 상온에서 방냉 후, 1,1,3,3-tetramethoxypropane을 표준물질로 532nm에서 흡광도를 측정한다.300 μl of Liposome and the functional substance to be measured are placed in a test tube, SDS (200 μl, 8.1% in water, v / v), acetic acid (1.5ml, 20%, w / v, 15% NaOH (w / v) PH 4.0), 2-thiobarbituric acid (1.5 ml, 0.8% in water, w / v), BHT (0.5 ml, 0.08% in MeOH, w / v) is added. This was reacted at 95 ° C. for 60 minutes in a water bath and allowed to cool at room temperature, and then measured for absorbance at 532 nm using 1,1,3,3-tetramethoxypropane as a standard.

[실험예 1-4] Hyaluronidase inhibition assayExperimental Example 1-4 Hyaluronidase inhibition assay

Hyaluronidase는 mucopolysaccharide를 가수분해하는 효소로써 hyaluronic acid를 분해하는 작용 이외에 모세혈관 투과성에 관여하며 급성부종을 야기하는 기염제로 알려져 있다. Hyaluronidase는 pH 3-4에서 가장 활성이 높은 특징이 있으며, 일반적으로 체내에선 불활성형으로 존재한다. 조직에서 일정농도가 유지되지만 알레르기, 혈관 투과성 염증반응, 조직손상 등에 의해 그 양이 증가하는 특징이 있다. 측정대상 기능성 물질은 [표 4]에 기재된 농도에 맞추어 각각 첨가하였다.Hyaluronidase is an enzyme that hydrolyzes mucopolysaccharides. In addition to its ability to decompose hyaluronic acid, hyaluronidase is known as a prophylactic agent that is involved in capillary permeability and causes acute edema. Hyaluronidase is most active at pH 3-4 and is generally inactive in the body. Although a certain concentration is maintained in tissues, the amount is increased due to allergies, vascular permeable inflammatory reactions, and tissue damage. The functional material to be measured was added according to the concentrations shown in [Table 4].

[실험방법 1-4] Hyaluronidase inhibition assay[Test Method 1-4] Hyaluronidase inhibition assay

Hyaluronidase를 Acetate buffer에 용해하고(7,900Unit/ml), 측정대상물질을 수용화한 시료 20㎕를 가한다. 이때 대조군으로는 MeOH를 사용한다. 이에 12.5mM CaCl2 100㎕를 가하고 37℃ 수욕상에서 20분 동안 반응시킨다. 위 반응 물질에 Hyaluronic acid를 가하고(12mg/5ml, acetate buffer), 이를 다시 37℃에서 40분 동안 반응시키고 0.4N NaOH, 0.4M Potassium tetraborate를 100㎕씩 가한다. 다시 수욕상에서 100℃/3min 반응시키고 상온까지 방냉한다. Dimethylaminobezaldehyde sol. 3ml를 가하고 다시 37℃ 수욕상에서 20분 동안 반응시킨 후 585nm에서 흡광도를 측정하여 다음 공식에 근거하여 그 능력을 평가한다.Dissolve Hyaluronidase in Acetate buffer (7,900 Units / ml), and add 20 µl of the sample containing the substance to be measured. In this case, MeOH is used as a control. 100 μl of 12.5 mM CaCl 2 was added thereto and reacted in a 37 ° C. water bath for 20 minutes. Hyaluronic acid is added to the above reaction material (12mg / 5ml, acetate buffer), which is then reacted at 37 ° C. for 40 minutes, and 100 μl of 0.4N NaOH and 0.4M Potassium tetraborate are added. Again, the reaction in 100 ℃ / 3 min in a water bath and allowed to cool to room temperature. Dimethylaminobezaldehyde sol. 3 ml is added and reacted for 20 minutes in a water bath of 37 ° C., then the absorbance is measured at 585 nm to evaluate its ability based on the following formula.

Hyaluronidase inhibitor(%)=[(ODcontrol-ODsample)/ODcontrol]×100Hyaluronidase inhibitor (%) = [(ODcontrol-ODsample) / ODcontrol] × 100

[실험결과] 통계처리[Experimental Results] Statistical Processing

측정된 자료는 SAS 통계 Package programme를 이용하여 분석하였으며, 결과 처리는 평균과 표준편차를 산정하였다. 각군의 평균치 비교는 분산분석 후 Duncan's multiple range test를 통해 유의 검정을 실시하였다. (p<0.05)The measured data were analyzed using the SAS Statistical Package Program, and the results were calculated using the mean and standard deviation. The mean value of each group was analyzed by Duncan's multiple range test after variance analysis. ( p <0.05)

[실험결과 1] Liposome을 기질로 한 항산화 및 항염증 능력 시험[Experiment 1] Antioxidant and Anti-inflammatory Capacity Test Using Liposome as Substrate

한약박과 유기셀레늄의 항산화 및 항염증 능력은 FOX assay 및 TBArs test를 통해서 확인하였다. 시험에 사용한 농도는 각각 5~100ppm 까지 적용하였으며, 이때 비교를 위해 천연 항산화제인 Ascorbate와 합성 항산화제인 BHT를 같은 방법으로 실험하였다. 중금속으로 인한 인공적인 산화 스트레스를 유발하기 위해 AAPH를 LUV 와 동시처리 하였으며, AAPH에 의해 증가한 과산화물의 양을 정량함으로써 각각의 능력을 평가하였다. Antioxidant and anti-inflammatory properties of Medicinal Herbs and organo selenium were confirmed by FOX assay and TBArs test. The concentrations used in the test were applied up to 5 ~ 100ppm, respectively. For comparison, Ascorbate, a natural antioxidant, and BHT, a synthetic antioxidant, were tested in the same way. In order to induce artificial oxidative stress due to heavy metals, AAPH was co-treated with LUV, and each capacity was evaluated by quantifying the amount of peroxide increased by AAPH.

[표 1]TABLE 1

Figure 112006097999306-pat00001
Figure 112006097999306-pat00001

[표 2]TABLE 2

Figure 112006097999306-pat00002
Figure 112006097999306-pat00002

[표 3]TABLE 3

Figure 112006097999306-pat00003
Figure 112006097999306-pat00003

[표 4]TABLE 4

Figure 112006097999306-pat00004
Figure 112006097999306-pat00004

표 1에 나타난 바와 같이 AAPH를 처리함에 따라 Hydroperoxide 및 Malonaldehyde의 농도가 높게 나타났다. 표 2와 표 3에 나타난 바와 같이 AAPH와 함께 항산화기능을 나타내는 측정대상물질을 처리한 결과, 전 시험군에서 측정대상 기능성물질의 농도가 증가함에 따라 항산화효과는 개선되었다. 특히, 한약박과 유기셀레늄을 동시 처리한 군에서는 별도 처리군에 비하여 강력한 항산화효과가 나타나 동시처리로 인한 상승효과를 확인할 수 있었다.As shown in Table 1, the concentration of Hydroperoxide and Malonaldehyde was high as AAPH was treated. As shown in Table 2 and Table 3, as a result of treating the measurement target with antioxidant function with AAPH, the antioxidant effect was improved as the concentration of the measurement target functional material increased in all the test groups. In particular, in the group treated with Medicinal Herb Park and organic selenium, a strong antioxidant effect appeared compared to the separate treatment group, confirming the synergistic effect due to the simultaneous treatment.

항염증시험은 강아지 모발과 병인과의 상관관계에 착안하여 시험을 수행하였으며, 측정대상 기능성물질의 사용에 따라 항염증효과 대별 요인으로서의 Hyaluronidase 억제효과를 살펴볼 수 있었다. 표 4에서 알 수 있듯이, 한약박의 경우 상당한 수준의 Hyaluronidase 억제효과를 가졌으며, 이에 반해 유기셀레늄 및 Ascorbate는 큰 효과를 갖지 못한 것으로 나타났다. 그러나, 유기셀레늄과 한약박을 동시 처리하였을 경우 한약박 단독으로 처리하였을 경우에 비해 억제효과가 개선되어 상승효과를 나타내었다.The anti-inflammatory test was carried out by focusing on the correlation between dog hair and etiology, and the inhibitory effect of hyaluronidase as an anti-inflammatory effect by the use of the functional substance to be measured was examined. As can be seen in Table 4, the herbal medicine had a significant level of inhibitory effect of Hyaluronidase, whereas organic selenium and Ascorbate did not have a significant effect. However, when the organic selenium and the herbal medicine was treated simultaneously, the inhibitory effect was improved compared to the treatment with the herbal medicine alone, showing a synergistic effect.

상기 실험예 1에 의하면 유기셀레늄과 한약박은 혼합물이 단독성분에 비하여 항산화 및 항염증 효과가 우수하며, 농도가 높을수록 효과도 우수한 것으로 나타났다. 그러나, 현행 사료관리법에 의하면 사료에 함유되는 셀레늄은 2ppm을 초과할 수 없도록 규정되어 있다. 또한, 애견을 대상으로 한약박을 첨가하여 사료를 급여한 결과, 한약박이 4ppm을 초과하는 경우 애견의 사료섭취량이 급격히 낮아졌으며, 이는 다량 첨가한 한약박의 향과 맛이 애견의 기호에 맞지 않기 때문인 것으로 판단되었다. 따라서, 실제 사료에 첨가하는 셀레늄과 한약박의 농도는 유기셀레늄 2ppm이하, 한약박 4ppm이하인 것이 바람직한 것으로 판단되었다.According to Experimental Example 1, the organic selenium and the herbal medicinal herb showed better antioxidative and anti-inflammatory effects than the mixture, and the higher the concentration, the better the effect. However, current feed management legislation requires that selenium in feed should not exceed 2 ppm. In addition, as a result of feeding the feed by adding medicinal herb to the dog, when the medicinal herb exceeds 4ppm, the feed intake of the dog was drastically lowered, which means that the aroma and taste of the medicinal herb added to the dog do not fit the taste of the dog. It was judged that. Therefore, it was determined that the concentrations of selenium and herbal medicine added to the actual feed should be 2 ppm or less of organic selenium and 4 ppm or less of herbal medicine.

[실험예 2] 동물시험Experimental Example 2 Animal Test

본 시험에 사용된 시험동물은 SD(Sprague-Dawley male rats, weighing approximately 180g and 6weeks old)이며, 각각의 시험군은 하기 표 5에 기재된 바와 같다. 시험동물은 완전임의배치법에 의해 처리군 별로 체중이 균일하게 군당 6수씩 배치하여 stainless steel cage에 넣고 1주간 주위 환경에 적응시킨 후 본 시험을 실시하였다. 총 시험기간은 6주였으며, 최초 시험 개시 시에 중금속 처리군에 대하여는 사료관리법상 허용 한계치까지 조제한 중금속 표준물질을 복강투여하였고, AAPH(2, 2'-azobis-2-amidinopropane-dihydrochloride) 처리군에 대하여는 도살 24시간 전에 AAPH 조제시료를 복강투여하였다. 측정대상 기능성 물질은 각 군당 매일 1회 경구투여 하였으며, 식이는 일반 사료 및 용수를 제한없이 급여하였다. 모발은 시험시작 직전, 시험시작 3주 후, 시험시작 6주 후 도살 직전으로 구분하여 매회 동일 등 부위에서 3회 채취하였다.The test animals used in this test are SD (Sprague-Dawley male rats, weighing approximately 180g and 6weeks old), and each test group is as described in Table 5 below. The test animals were placed in a stainless steel cage with 6 weights per group uniformly for each treatment group by the complete randomization method, and then adapted to the surrounding environment for 1 week. The total test period was 6 weeks. At the beginning of the initial test, the heavy metal treatment group was intraperitoneally administered the heavy metal standard prepared to the limit of food control law, and the AAPH (2, 2'-azobis-2-amidinopropane-dihydrochloride) treatment group. About 24 hours before slaughter, AAPH preparations were intraperitoneally administered. The functional substance to be measured was administered orally once a day for each group, and diet was fed without restriction on general feed and water. Hair was collected three times at the same back area each time, immediately before the start of the test, three weeks after the start of the test, and six weeks after the start of the test.

시험기간 중 1주일마다 체중을 측정하였으며, 6주 후 해독능력을 판정하기 위하여 전수 도살하고, 간 및 혈액을 채취하여 각각의 시료에 대한 중금속 침착도 및 산화지수평가, sGOT, sGPT 시험 등을 실시하였다.The body weight was measured every week during the test period. After 6 weeks, the whole body was slaughtered to determine the detoxification ability, and the liver and blood were collected to perform heavy metal deposition and oxidation index evaluation, sGOT, and sGPT tests. It was.

[표 5]TABLE 5

Figure 112006097999306-pat00005
Figure 112006097999306-pat00005

[실험예 2-1] 혈청 및 간의 산화지수 평가Experimental Example 2-1 Evaluation of Oxidation Index of Serum and Liver

생체에서 해독능력을 부여받은 간 조직의 경우 항산화 효과에 대해 상당히 민감하게 반응한다. 간 조직은 일련의 단백질 및 지질의 복합화 된 Lipo-protein 형태로 존재하므로 산화 스트레스에 의해 과산화물의 생성이 급격하게 증가하여, 간 조직에서의 산화 스트레스 검증을 위해 TBArs 실험을 실시하였으며(Ohkawa et al, 1979), 간 조직 역시 조직 내 중금속 변화 추이를 검증하였다.Liver tissues that are detoxified in vivo are quite sensitive to antioxidant effects. Since liver tissue exists in the form of a complexed Lipo-protein of a series of proteins and lipids, peroxide production is rapidly increased by oxidative stress, and TBArs experiments were conducted to verify oxidative stress in liver tissue (Ohkawa et al , 1979), hepatic tissue also examined the trend of heavy metal changes in tissues.

[실험예 2-2] Enzymatic assayExperimental Example 2-2 Enzymatic assay

sGOT 및 sGPT는 AAPH등의 산화 스트레스에 대해 민감하게 변화하는 효소로 산화 스트레스가 유발될 경우 간에서 혈중으로 급격히 분비된다. 따라서 산화 스트 레스에 의해 혈중 역가가 높게 나타나게 되므로, AAPH 및 중금속 유발로 인한 산화 스트레스를 대별하는 측정지수로 활용하였다. 전 시험은 Eiken사에서 공급받은 분석 Kit를 이용하여 분석하였다.sGOT and sGPT are enzymes that are sensitive to oxidative stress, such as AAPH, and are rapidly secreted into the blood by the liver when oxidative stress is induced. Therefore, since the blood titer appears to be high due to oxidative stress, it was used as a measurement index to distinguish oxidative stress caused by AAPH and heavy metal induction. All tests were analyzed using an analysis kit supplied by Eiken.

[실험예 2-3] 중금속 침착도 시험Experimental Example 2-3 Heavy Metal Deposition Test

모발은 초기, 중기, 도축시로 구분하여 매회 동일 등 부위에서 3회 채취하였으며, 수집된 모발은 채취 즉시 ICP-AES를 이용하여 중금속 침착도를 시험하였다. 또한, 간과 혈액도 채취 즉시 동일 방법으로 시험하였다.Hair was collected three times from the same site each time, divided into initial, middle, and slaughtered, and the collected hair was tested for heavy metal deposition using ICP-AES immediately after collection. Liver and blood were also tested in the same manner immediately after collection.

[실험결과] 통계처리[Experimental Results] Statistical Processing

측정된 자료는 SAS 통계 Package programme를 이용하여 분석하였으며, 결과 처리는 평균과 표준편차를 산정하였다. 각군의 평균치 비교는 분산분석 후 Duncan's multiple range test를 통해 유의 검정을 실시하였다. (p<0.05)The measured data were analyzed using the SAS Statistical Package Program, and the results were calculated using the mean and standard deviation. The mean value of each group was analyzed by Duncan's multiple range test after variance analysis. ( p <0.05)

[실험결과 2] 동물시험[Test Result 2] Animal Test

시험기간 중 체중의 변화는 도 2에 나타내었으며, 도 2에 의하면 체중에 있어서 시험군 간의 유의한 차이는 발견할 수 없었다.The change in body weight during the test period is shown in FIG. 2, and according to FIG. 2, no significant difference was found between the test groups.

[실험결과 2-1] 혈청 및 간의 산화지수 평가 시험[Experiment 2-1] Oxidation Index Evaluation Test

시험동물 도체에서 적출한 혈청 및 간 시료에 대한 산화지수 평가는 TBArs test를 통해 시험하였으며, 결과는 도 3과 도 4에 나타내었다.Oxidation index evaluation of the serum and liver samples extracted from the test animal carcass was tested by the TBArs test, the results are shown in Figures 3 and 4.

도 3과 도 4에 나타난 결과에 의하면 혈청과 간 사이의 경향성 차이는 없는 것으로 판단되며, 중금속 처리군에서 malonaldehyde 수치가 높게 나타나 중금속에 의한 Free radical의 생성을 확인할 수 있었다. 또한, 한약박과 유기셀레늄에 혼합물에 의한 항산화 효과를 확인할 수 있었다. 다만, 시험에 사용된 한약박의 농도 비율에 비해 산화 스트레스 억제에 관여하는 효과는 차이가 적은 것으로 미루어, 산화 억제를 위하여 사용된 한약박의 농도가 포화에 가까운 것으로 판단되었다. According to the results shown in FIGS. 3 and 4, there is no difference in the tendency between the serum and the liver. The malonaldehyde level was high in the heavy metal treatment group, thereby confirming the production of free radicals by the heavy metal. In addition, it was confirmed that the antioxidant effect of the mixture of herbal medicine and organic selenium. However, since the effect of oxidative stress inhibition was small compared to the concentration ratio of the herbal medicine used in the test, it was judged that the concentration of the herbal medicine used for the inhibition was close to saturation.

[실험결과 2-2] 혈중 sGOT 및 sGPT 역가 시험[Experiment 2-2] Blood sGOT and sGPT titer test

혈중 sGOT 및 sGPT 역가 시험결과는 도 5에 나타내었다.Blood sGOT and sGPT titer test results are shown in FIG. 5.

도 5에 의하면 외부 스트레스에 의해 간에서 혈중으로 분비되는 sGOT 및 sGPT의 혈중 역가 또한 산화지수 평가 시험과 거의 동일한 경향성을 나타냈다. 즉, AAPH 및 중금속 처리군의 경우 급격하게 증가되는 sGOT 및 sGPT 역가를 살펴볼 수 있었으나, 유기셀레늄과 한약박 사용에 의해 다시 안정되는 추세를 확인할 수 있었다. 다만 산화지수 평가 시험과 마찬가지로 한약박 농도를 달리한 처리군 간의 유의차가 크게 발생하지 않는 것으로 미루어 보아 한약박의 농도가 포화에 가까운 것으로 판단되었다.According to FIG. 5, blood titers of sGOT and sGPT secreted into the blood by external stress also showed almost the same tendency as the oxidative index evaluation test. That is, in the case of AAPH and heavy metal treatment group, the sGOT and sGPT titers were rapidly increased, but it was confirmed that the trend was stabilized again by using organic selenium and herbal medicine. However, as in the oxidation index evaluation test, it was judged that the concentration of the herbal medicine was close to saturation, considering that there was no significant difference between treatment groups having different concentrations of the herbal medicine.

[실험결과 2-3] 모발, 간 및 혈중 중금속 침착 억제효과 평가 시험[Experimental Result 2-3] Evaluation Test for Inhibitory Effect of Heavy Metal Deposition in Hair, Liver and Blood

본 시험의 최종 목표인 모발 분석과 간 및 혈중 중금속 분석을 통한 상관관계 도출을 위해 수집된 동물 모발과 시험 종료 시 적출한 간 및 혈액 시료 내 중금속 분포도를 측정하였다. 모발시료의 측정결과는 표 6에, 간 시료 측정결과는 표 7에, 혈액 시료 측정결과는 표 8에, ppm의 단위로 각각 나타내었다.The distribution of heavy metals in collected animal hair and liver and blood samples collected at the end of the study was determined to correlate the final goal of this study with hair analysis and liver and blood heavy metal analysis. The measurement results of the hair samples are shown in Table 6, the liver sample measurement results in Table 7, and the blood sample measurement results in Table 8, in ppm units.

[표 6]TABLE 6

Figure 112006097999306-pat00006
Figure 112006097999306-pat00006

[표 7]TABLE 7

Figure 112006097999306-pat00007
Figure 112006097999306-pat00007

[표 8]TABLE 8

Figure 112006097999306-pat00008
Figure 112006097999306-pat00008

상기 표 6의 모발 분석 결과 시험기간이 진행되면서 점차 모발 내 침착되어 있는 중금속의 양은 자연적으로 감소하는 경향을 나타내었다. 그러나, 중금속 처리군의 경우 감소율이 상대적으로 낮았으며, 유기셀레늄과 한약박 혼합물 처리군 경우 감소율이 확연히 높게 나타났다. 특히, 유기셀레늄 2ppm, 한약박 4ppm 처리군에서 가장 높은 개선효과를 살펴볼 수 있었으며, 이에 준하여 조제 사료를 급여할 경우 항산화효과 및 sGOT 및 sGPT 역가 개선에 의한 간기능 보호효과 또한 기대할 수 있으리라 사료된다. 표 7과 표 8의 간 및 혈중 중금속 분포 또한 모발 분석과 유사한 경향성을 나타내어 모발 분석과 간 및 혈액으로 대별되는 조직 분석 간의 상관관계를 도출할 수 있었다. 다만, 한약박 농도에 따른 차이를 간 및 혈중에서는 확인할 수 없었으며, 이는 간의 대표적인 기능인 해독능력 및 완충능력에 기인한 것으로 판단된다.As a result of the hair analysis of Table 6, the amount of heavy metals deposited in the hair gradually decreased as the test period progressed. However, the reduction rate was relatively low in the heavy metal treatment group, and the reduction rate was significantly higher in the organic selenium and herbal medicine mixture treatment group. In particular, the highest improvement was found in the 2ppm organic selenium and 4ppm medicinal herbs, and accordingly, the dietary supplementation could be expected to have anti-oxidant effect and liver function protection by sGOT and sGPT titer improvement. The distribution of heavy metals in the liver and blood of Table 7 and Table 8 also showed similar trends with the hair analysis, and it was possible to derive a correlation between the hair analysis and the tissue analysis classified into liver and blood. However, the difference according to the concentration of herbal medicine could not be confirmed in the liver and blood, which is considered to be due to the detoxification and buffering capacity, which are typical functions of the liver.

결과를 종합하면 한약박과 유기셀레늄 혼합물은 동물의 체내에 침착된 중금속의 농도를 낮추고 항산화, 항염증 효과를 지니므로, 사료에 첨가하여 급여할 경우 가축이나 애완동물의 중금속 중독으로 인한 질환을 예방 및 치료할 수 있을 것으로 사료된다. Taken together, herbal medicines and organic selenium mixtures lower the concentration of heavy metals deposited in the body and have antioxidant and anti-inflammatory effects. Therefore, when added to feeds, it prevents diseases caused by heavy metal poisoning in livestock or pets. And be curable.

유기셀레늄과 한약박분말은 사료에 다량 첨가할 경우 항산화, 항염증 및 중금속제거의 효과는 높아진다. 그러나, 유기셀레늄을 다량 첨가하는 경우, 사료관리법의 허용수치를 벗어날 뿐 아니라 비용이 상승하므로 바람직하지 못하고, 한약박분말의 경우 2-4ppm의 범위에서 효과의 차이가 크지 않으므로 그 이상 함유한다 하더라도 효과의 차이는 미미할 것으로 예상되며, 한약박을 다량 함유하는 사료는 애완동물의 기호에 맞지 않는 문제가 있다. 따라서, 유기셀레늄 2ppm, 한약박분말 2-4ppm을 사료에 함유시키는 것이 바람직한 것으로 판단된다.Organic selenium and Chinese herbal medicine powder are effective in antioxidant, anti-inflammatory and heavy metal removal when added to feed. However, when a large amount of organic selenium is added, it is not preferable not only because it exceeds the allowable value of the feed management method, but also because the cost increases, and the herbal medicine powder does not have a large difference in effect in the range of 2-4 ppm. The difference is expected to be small, the feed containing a large amount of herbal medicine has a problem that does not fit the pet's taste. Therefore, it is considered that it is preferable to include 2 ppm of organic selenium and 2-4 ppm of herbal powder in the feed.

본 발명에 따른 사료는 한약박과 유기셀레늄을 함유하여 가축이나 애완동물 의 체내에 쌓인 중금속으로 인한 중독증상을 예방 및 치료하는 효과를 지니며, 더불어 항산화 및 항염증 효과를 나타낸다. 따라서, 가축이나 애완동물의 질병요인을 막고 건강을 유지할 수 있도록 도와주며, 더불어 고부가가치를 지닌 기능성 원료를 공급함으로써 침체 되어있는 국내 사료산업의 활성화에 일조할 수 있다.Feed according to the present invention has the effect of preventing and treating poisoning symptoms due to heavy metals accumulated in the body of livestock or pets by containing herbal medicine and organic selenium, and also has an antioxidant and anti-inflammatory effect. Therefore, it helps to prevent disease factors of livestock and pets and maintains health, and can also contribute to revitalizing stagnant domestic feed industry by supplying high value-added functional raw materials.

Claims (2)

유기셀레늄 2ppm, 한약박분말 2-4ppm을 함유하는 것을 특징으로 하는 중금속중독질환 예방용 사료.Organic selenium 2ppm, Chinese medicine powder containing 2-4ppm heavy metal poisoning disease prevention feed. 제1항에 있어서, 애완동물의 중금속중독질환 예방용 사료.The pet food for preventing heavy metal poisoning diseases of claim 1.
KR1020060137417A 2006-12-29 2006-12-29 Feed for prevention of heavy metal poisoning KR100785375B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060137417A KR100785375B1 (en) 2006-12-29 2006-12-29 Feed for prevention of heavy metal poisoning

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060137417A KR100785375B1 (en) 2006-12-29 2006-12-29 Feed for prevention of heavy metal poisoning

Publications (1)

Publication Number Publication Date
KR100785375B1 true KR100785375B1 (en) 2007-12-18

Family

ID=39147045

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060137417A KR100785375B1 (en) 2006-12-29 2006-12-29 Feed for prevention of heavy metal poisoning

Country Status (1)

Country Link
KR (1) KR100785375B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150132979A (en) 2014-05-19 2015-11-27 주식회사 알파벳 Ginseng Berry assisted pet food manufacturing method
KR20180077893A (en) 2016-12-29 2018-07-09 주식회사 알파벳 Feed composition for pet animal comprising Oxya chinensis sinuosa Mistshenko
KR20240028239A (en) 2022-08-24 2024-03-05 이인겸 Manufacturing method of functional convenience color feed for pets and functional convenience color feed for pets manufactured by the method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880000062A (en) * 1986-06-12 1988-03-23 다데이시 다까오 Electronic sphygmomanometer
KR100528720B1 (en) * 2002-08-29 2005-11-15 주식회사 메디넥스 Nutritional composition of health food inhibiting heavy metal accumulation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880000062A (en) * 1986-06-12 1988-03-23 다데이시 다까오 Electronic sphygmomanometer
KR100528720B1 (en) * 2002-08-29 2005-11-15 주식회사 메디넥스 Nutritional composition of health food inhibiting heavy metal accumulation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
웹(http://blog.empas.com/dotodtk/8862998) "역시 ‘약방의 감초’… 중금속 해독에도 특효"( 2005/05/31 (화) 16:10 )

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150132979A (en) 2014-05-19 2015-11-27 주식회사 알파벳 Ginseng Berry assisted pet food manufacturing method
KR101721729B1 (en) 2014-05-19 2017-04-10 주식회사 알파벳 Ginseng Berry assisted pet food manufacturing method
KR20180077893A (en) 2016-12-29 2018-07-09 주식회사 알파벳 Feed composition for pet animal comprising Oxya chinensis sinuosa Mistshenko
KR20240028239A (en) 2022-08-24 2024-03-05 이인겸 Manufacturing method of functional convenience color feed for pets and functional convenience color feed for pets manufactured by the method

Similar Documents

Publication Publication Date Title
Hoseini et al. Antioxidant, enzymatic and hematological responses of common carp (Cyprinus carpio) fed with myrcene-or menthol-supplemented diets and exposed to ambient ammonia
Hayek et al. Reduced progression of atherosclerosis in apolipoprotein E–deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation
Aviram et al. Pomegranate protection against cardiovascular diseases
Jiang et al. Myo-inositol prevents copper-induced oxidative damage and changes in antioxidant capacity in various organs and the enterocytes of juvenile Jian carp (Cyprinus carpio var. Jian)
Biswas et al. Effect of dietary Japanese green tea powder supplementation on feed utilization and carcass profiles in broilers
TWI375031B (en) Antioxidant sensor and methods
Décordé et al. Phenolics from purple grape, apple, purple grape juice and apple juice prevent early atherosclerosis induced by an atherogenic diet in hamsters
Tanaka et al. A xanthine oxidase inhibitor 1'-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats.
Alimi et al. Protective effect of Opuntia ficus indica f. inermis prickly pear juice upon ethanol-induced damages in rat erythrocytes
Koriem et al. Therapeutic effect of pectin on octylphenol induced kidney dysfunction, oxidative stress and apoptosis in rats
Anwar et al. Amelioration of liver and kidney functions disorders induced by sodium nitrate in rats using wheat germ oil
CN101287480B (en) Anti-inflammatory compositions and methods of use
US7887848B2 (en) Nutraceutical treatments for diabetic and non-diabetic wound healing
WO2000019999A1 (en) Fulvic acid and its use in the treatment of various conditions
Ashour et al. Role of fast green on the blood of rats and the therapeutic action of vitamins C or E
Udomkasemsab et al. Maoberry (Antidesma bunius) improves glucose metabolism, triglyceride levels, and splenic lesions in high-fat diet-induced hypercholesterolemic rats
Yacoubi et al. Anti-oxidative and anti-inflammatory effects of Trigonella foenum-graecum Linnaeus, 1753 (Fenugreek) seed extract in experimental pulmonary fibrosis
Avdagić et al. Spirulina platensis protects against renal injury in rats with gentamicin-induced acute tubular necrosis
Utsunomiya et al. Anti-hyperglycemic effects of plum in a rat model of obesity and type 2 diabetes, Wistar fatty rat
Tartila et al. Evaluation of dietary supplementation with cinnamon products on growth, blood composition, liver structure, and meat quality of striped catfish (Pangasianodon hypophthalmus)
KR100785375B1 (en) Feed for prevention of heavy metal poisoning
Chowdhury et al. Resveratrol treatment modulates several antioxidant and anti-inflammatory genes expression and ameliorated oxidative stress mediated fibrosis in the kidneys of high-fat diet-fed rats
WO2007143631A2 (en) Nutraceutical treatments for diabetic and non-diabetic wound healing
Aktaş et al. Protective effects of rutin on acute lung injury induced by oleic acid in rats
Ihedioha et al. Effects of aqueous leaf infusion of Pterocarpus santalinoides DC on serum lipid profile of guinea pigs (Carvia porcellus)

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121206

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20131205

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20150608

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20151207

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20170406

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20180108

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20190401

Year of fee payment: 12